Cargando…
Synthesis, Biodistribution, and Radiation Dosimetry of a Novel mGluR5 Radioligand: (18)F-AZD9272
[Image: see text] The metabotropic glutamate receptor subtype mGluR5 has been proposed as a potential drug target for CNS disorders such as anxiety, depression, Parkinson’s disease, and epilepsy. The AstraZeneca compound AZD9272 has previously been labeled with carbon-11 and used as a PET radioligan...
Autores principales: | Nag, Sangram, Varnäs, Katarina, Arakawa, Ryosuke, Jahan, Mahabuba, Schou, Magnus, Farde, Lars, Halldin, Christer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309225/ https://www.ncbi.nlm.nih.gov/pubmed/32167745 http://dx.doi.org/10.1021/acschemneuro.9b00680 |
Ejemplares similares
-
PET Evaluation
of the Novel F-18 Labeled Reversible
Radioligand [(18)F]GEH200449 for Detection of Monoamine Oxidase-B
in the Non-Human Primate Brain
por: Varnäs, Katarina, et al.
Publicado: (2023) -
Characterization of a Novel M4 PAM PET Radioligand [11C]PF06885190 in Nonhuman Primates (NHP)
por: Nag, Sangram, et al.
Publicado: (2023) -
Potential for imaging the high-affinity state of the 5-HT(1B) receptor: a comparison of three PET radioligands with differing intrinsic activity
por: Lindberg, Anton, et al.
Publicado: (2019) -
Effects of sevoflurane anaesthesia on radioligand binding to monoamine oxidase-B in vivo
por: Varnäs, Katarina, et al.
Publicado: (2021) -
Synthesis and Autoradiography of Novel F-18
Labeled Reversible Radioligands for Detection of Monoamine Oxidase
B
por: Nag, Sangram, et al.
Publicado: (2020)